Preferences help
enabled [disable] Abstract
Number of results
2013 | 9 | 4 | 331-337
Article title

Przewlekła choroba nerek a starzenie się populacji

Title variants
Chronic kidney disease and the aging population
Languages of publication
Physical description
  • University of Alberta, Alberta, Canada
  • Catholic University of Parana, Curitiba, Brazil
  • 1. World Health Organization: Good health adds life to years: Global brief for World Health Day 2012. Geneva 2012.
  • 2. Wiener J.M., Tilly J.: Population aging in the United States of America: implications for public programmes. Int. J. Epidemiol. 2002; 31: 776–781.
  • 3. Couser W.G., Remuzzi G., Mendis S., Tonelli M.: The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011; 80: 1258–1270.
  • 4. Select Committee on Public Service and Demographic Change. Ready for Aging? Report. House of Lords, London 2013.
  • 5. Davies D.F., Shock N.W.: Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J. Clin. Invest. 1950; 29: 496–507.
  • 6. Zhang L., Wang F., Wang L. i wsp.: Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 2012; 379: 815–822.
  • 7. Coresh J., Selvin E., Stevens L.A. i wsp.: Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038–2047.
  • 8. Zhang Q.L., Rothenbacher D.: Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008; 8: 117.
  • 9. Arora P., Vasa P., Brenner D. i wsp.: Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ 2013; 185: E417–E423.
  • 10. James M.T., Hemmelgarn B.R., Tonelli M.: Early recognition and prevention of chronic kidney disease. Lancet 2010; 375: 1296–1309.
  • 11. Kurella M., Covinsky K.E., Collins A.J., Chertow G.M.: Octogenarians and nonagenarians starting dialysis in the United States. Ann. Intern. Med. 2007; 146: 177–183.
  • 12. Hemmelgarn B.R., James M.T., Manns B.J. i wsp.: Rates of treated and untreated kidney failure in older vs younger adults. JAMA 2012; 307: 2507–2515.
  • 13. Keith D.S., Nichols G.A., Gullion C.M. i wsp.: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch. Intern. Med. 2004; 164: 659–663.
  • 14. Hemmelgarn B.R., Manns B.J., Lloyd A. i wsp.: Relation between kidney function, proteinuria, and adverse outcomes. JAMA 2010; 303: 423–429.
  • 15. O’Hare A.M., Bertenthal D., Covinsky K.E. i wsp.: Mortality risk stratification in chronic kidney disease: one size for all ages? J. Am. Soc. Nephrol. 2006; 17: 846–853.
  • 16. Stevens P.E., Levin A.; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members: Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann. Intern. Med. 2013; 158: 825–830.
  • 17. Thorsteinsdottir B., Montori V.M., Prokop L.J., Murad M.H.: Ageism vs. the technical imperative, applying the GRADE framework to the evidence on hemodialysis in very elderly patients. Clin. Interv. Aging 2013; 8: 797–807.
  • 18. Chandna S.M., Da Silva-Gane M., Marshall C. i wsp.: Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy. Nephrol. Dial. Transplant. 2011; 26: 1608–1614.
  • 19. Murtagh F.E., Marsh J.E., Donohoe P. i wsp.: Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol. Dial. Transplant. 2007; 22: 1955–1962.
  • 20. Kurella Tamura M., Covinsky K.E., Chertow G.M. i wsp.: Functional status of elderly adults before and after initiation of dialysis. N. Engl. J. Med. 2009; 361: 1539–1547.
  • 21. Lamping D.L., Constantinovici N., Roderick P. i wsp.: Clinical outcomes, quality of life, and costs in the North Thames Dialysis Study of elderly people on dialysis: a prospective cohort study. Lancet 2000; 356: 1543–1550.
  • 22. Unruh M.L., Newman A.B., Larive B. i wsp.: The influence of age on changes in health-related quality of life over three years in a cohort undergoing hemodialysis. J. Am. Geriatr. Soc. 2008; 56: 1608–1617.
  • 23. Knoll G.A.: Kidney transplantation in the older adult. Am. J. Kidney Dis. 2013; 61: 790–797.
  • 24. Merion R.M., Ashby V.B., Wolfe R.A. i wsp.: Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 2005; 294: 2726–2733.
  • 25. Cohen B., Smits J.M., Haase B. i wsp.: Expanding the donor pool to increase renal transplantation. Nephrol. Dial. Transplant. 2005; 20: 34–41.
  • 26. Gill J., Bunnapradist S., Danovitch G.M. i wsp.: Outcomes of kidney transplantation from older living donors to older recipients. Am. J. Kidney Dis. 2008; 52: 541–552.
  • 27. Gill J.S., Tonelli M., Johnson N. i wsp.: The impact of waiting time and comorbid conditions on the survival benefit of kidney transplantation. Kidney Int. 2005; 68: 2345–2351.
  • 28. O’Hare A.M., Kaufman J.S., Covinsky K.E. i wsp.: Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: is the evidence base relevant to older adults? Ann. Intern. Med. 2009; 150: 717–724.
  • 29. Mohanlal V., Weir M.: Kidney transplantation in the elderly: it’s not all gloom and doom. ASN Kidney News 2011; 3: 15–17.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.